Ceat Ltd (CEAT IN) Competitive scenario easing?

Similar documents
KDDL (KDDL IN) In expansion mode

Colgate Palmolive (CLGT IN) Volume growth revival is the biggest positive

Indo Count (ICNT IN) Cost and currency impacted the margins

The India Cements Ltd (ICEM IN) Volumes consistency maintained, confident of regaining pricing power

BHEL (BHEL IN) Weak execution and margins lead to the miss in earnings

CG Power (CGPOWER IN) Analyst meet takeaways

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability

Manappuram Finance (MGFL IN) Healthy operating performance

Atul Ltd (ATLP IN) Sustained price & AkzoNobel JV to drive value growth

Larsen & Toubro (LT IN) Shines on all parameters and we get constructive

BHEL (BHEL IN) Margins continue to disappoint

Aarti Industries (ARTO IN) A structural specialty chemical growth play

Larsen & Toubro (LT IN) Well played on all fronts but for margins

Infosys (INFO IN) Strong performance; small miss on margins maintain BUY

NIIT Technologies (NITEC IN) Strong performance across the board; maintain BUY

HDFC Bank (HDFCB IN) Continue to perform strong

Asian Paints (APNT IN) Not a colorful performance

PhillipCapital-Actionable Trades (P-ACT)

Emami (HMN IN) Seasonality jinx continues

Camlin Fine Sciences (CFIN IN) At the inflexion point

ICICI Bank (ICICIBC IN) Strong improvement in asset quality

Hindustan Unilever Ltd (HUVR IN) Gross margin pressure managed well

depreciation the stood at 1.4x 2%) positive impacted by impact of INR share in the room duty continue to UCP vs months

IT Services Deal Monitor: ISG 3QCY18 Takes a breather

Mahindra & Mahindra (MM IN) Robust quarter, largely in line

Ramkrishna Forgings (RMKF IN) Marginally ahead, story intact

Apollo Tyres (APTY IN) Hungary Plant Visit: Finally benefiting from its greenfield expansion

Nalco (NACL IN) Alumina volumes drive profits

BHEL (BHEL IN) Elevated provisions and taxes led to the disappointment

Larsen & Toubro (LT IN) In line results; current orders momentum is a positive

Monetary Policy A sound monetary policy on all parameters after a long time

India Banking Trends Q2FY19 results review: Early signs of the credit cost cycle normalising

Voltas Limited (VOLT IN) Higher margins offset weak revenues

TVS Motors. Source: Company Data; PL Research

Manappuram Finance (MGFL IN) Operating performance was below expectation

India Strategy Adding currency play to consumption

FLASH NOTE Welspun India 31 Jan 17

Tata Steel (TATA IN) Is Bhushan a Corus Part 2? We don t think so

Mahindra and Mahindra Maintain Outperformer. (Rs mn) Mar 14 Mar 15 YoY (%) Dec 14 QoQ (%) FY14 FY15P YoY (%) FY16E YoY (%) FY17E YoY (%)

Ceat Ltd (CEAT IN) Weak quarter, margin pressure to prevail

ABB India (ABB IN) Bottom cycle valuation despite stable outlook

Initiating Coverage. Uflex Ltd.

Q4 EARNINGS REPORT Welspun India 25 Apr 17

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Tata Elxsi Ltd. CMP: Rs. 1,192 Future Stallion.. BUY. Stock Data. Stock Performance (%) Company Update IT Software India Research

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

Nestle India (NEST IN) Altius, Citius, Fortius

Mahindra & Mahindra. Source: Company Data; PL Research

Ceat Ltd (CEAT IN) Strong operating performance, capex advanced

Coal India (COAL IN) Strong volumes and cost control drive profitability

Phillips Carbon Black Ltd

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

LARGE CAP & 1,970 BSE

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Ramkrishna Forgings (RMKF IN) Best is yet to come

India Cements Rating: Target price:

Maruti Suzuki (MSIL IN) Steady performance, royalty to decrease

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

India Banking Trends Q3FY19 results review: A step forward towards normalized credit cost

Near-term pressure, but long-term outlook positive

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

Alstom T&D (ATD IN) Earnings dented by lower margins

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

KDDL (KDDL IN) PAN card notification continues to hurt retail profitability

Financials The wait for recoveries is getting longer

Coal India. Source: Company Data; PL Research

MCX Ltd. Rating: Target price: EPS: Is commodity option a game changer for MCX? - Unlikely. Target. Rating CMP. Rs. 1,080 SELL. Rs.

HDFC Standard Life Insurance

PTC India (PTC IN) Strong core trading margins

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Maruti Suzuki. Source: Company Data; PL Research

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Tata Steel (TATA IN) And a beat again; strong performance continues

Phillips Carbon Black Ltd

Symphony Ltd. RESULT UPDATE 31st October 2017

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

Cummins India (KKC IN) GST led disruption in sales impacted earnings

JK Lakshmi Cement. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Ambuja Cements (ACEM IN) No structural issues realisation impact tones down earnings

Coal India. Source: Company Data; PL Research

Key estimate revision. Financial summary. Year

Tata Motors (TTMT IN) Tough world, downgrade to Neutral

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

Result Update. Sterling Tools. Buy

CMP: Stock Data Sector. Stock Performance (%) Shareholding Pattern (%) Sensex and stock movement. 6 th March, 2017

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

Century Plyboards (I) Limited

Maruti Suzuki (MSIL IN) Strong margin performance

PTC India (PTC IN) Volumes hit by transmission constraints

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Bajaj Auto (BJAUT IN) Robust margin expansion on better product mix

Adani Ports & SEZ Rating: Target price: EPS:

Ashok Leyland. Source: Company Data; PL Research

Transcription:

INSTITUTIONAL EQUITY RESEARCH Ceat Ltd (CEAT IN) Competitive scenario easing? INDIA AUTOMOBILES Company Update Ceat has underperformed its peers CYTD with the stock falling by more than 25% mainly because MRF became aggressive in Ceat s bread and butter two wheeler segment, which led to restricted price hikes and volume growth. Our industry checks suggest that the competitive scenario in the 2W segment is easing. MRF, which had become aggressive in the 2W replacement segment since November 2017, has scaled back its strategy and has stopped aggressive channel filing after its retail sales failed to pick up with equal strength. Checks indicate that Ceat had taken a 1% price hike in the 2W segment in July, and MRF followed suit in August. The industry expects both players to take another 2W price hike in September. Kerala floods have resulted in production losses for MRF and Apollo, which has created a supply deficit in the channel, benefiting Ceat and JKTY. With the recent rise in domestic natural rubber prices, players have increased off take from Thailand rubber companies by 15 20%; 1 2% price hike is likely in PCR and MHCV segments in the coming week. MRF scaling back its aggression MRF had become aggressive in Ceat s bread butter two wheeler segment since November 2017. Unlike its past strategy of controlled supply and creating artificial supply deficit, it started bombarding its dealers with excess supply of two wheeler tyres in order to restrict both price hikes and Ceat s consistent market share gains (Ceat at c.30% vs. MRF c.36%). Our checks suggest that MRF has scaled back this aggression since June 2018 as its retail sales failed to pick up equally. This led to stronger growth for Ceat in the 2W replacement, which has averaged over 900,000/month since June vs. 775,000 before that. Ceat has also gained leadership in the scooters replacement segment, pipping MRF at c.300,000 units of monthly sales. Recently, it hiked prices by about 1%, followed soon by MRF; both players are contemplating another hike in 2Ws by mid September. Kerala floods have created supply deficit in the industry Unfortunate flooding in Kerala has meant domestic rubber prices hardening by ~5%, which has led to tyre companies increasing rubber off take from Thailand by 15 20%. The industry is looking at a 1 2% price hike in PCR and MHCV segments in the next fortnight. Kerala floods have also meant lower production from Apollo and MRF, which has created a supply deficit in the channel, benefiting Ceat and JKTY. Valuation After significant underperformance, we see Ceat outperforming if the trend of MRF scaling back its aggression in the two wheeler segment sustains. Hampered production (of competitors) due to recent floods in Kerala has helped Ceat in the near term. We see strong traction in 2HFY19, led by MRF s inability to deter CEAT, a new TBR capacity coming on stream from Q3FY19, and pricing power in the truck segment. RM price surge is the key risk to our thesis. Maintain BUY with a target of Rs 1,800, valuing the company at 14x FY20 earnings. 30 August 2018 BUY (Maintain) CMP RS 1417 TARGET RS 1800 (27%) COMPANY DATA O/S SHARES (MN) : 40 MARKET CAP (RSBN) : 58 MARKET CAP (USDBN) : 0.8 52 WK HI/LO (RS) : 2030 / 1229 LIQUIDITY 3M (USDMN) : 13.6 PAR VALUE (RS) : 10 SHARE HOLDING PATTERN, % Jun 18 Mar 18 Dec 17 PROMOTERS : 50.8 50.8 50.8 FII / NRI : 20.3 22.4 25.1 FI / MF : 11.7 11.7 10.2 NON PRO : 5.8 5.4 4.6 PUBLIC & OTHERS : 11.5 9.8 9.3 PRICE PERFORMANCE, % 1MTH 3MTH 1YR ABS 2.5 3.1 13.6 REL TO BSE 1.5 7.4 36.0 PRICE VS. SENSEX 200 150 100 50 0 A 16 O 16 A 17 O 17 A 18 CEAT BSE Sensex KEY FINANCIALS Rs mn FY18 FY19E FY20E Net Sales 62,308 71,118 81,223 EBIDTA 6,148 8,795 10,568 Net Profit 2,673 4,590 5,500 EPS, Rs 65.7 112.8 135.1 PER, x 21.6 12.6 10.5 EV/EBIDTA, x 10.5 8.5 7.7 PBV, x 2.2 2.0 1.7 ROE, % 10.3 15.5 16.1 Debt/Equity (%) 27.4 61.2 76.5 Source: Phillip Capital India Research Nitesh Sharma, CFA (+ 9122 6246 4126) nsharma@phillipcapital.in Vipul Agrawal (+ 9122 6246 4127) vagrawal@phillipcapital.in Page 1 PHILLIPCAPITAL INDIA RESEARCH

CEAT LTD COMPANY UPDATE Financials Income Statement Net sales 57,665 62,308 71,118 81,223 Growth, % 1 8 14 14 Other income 0 0 0 0 Total income 57,665 62,308 71,118 81,223 Raw material expenses 33,623 38,100 43,121 48,725 Employee expenses 4,063 4,383 4,623 5,280 Other Operating expenses 13,037 13,677 14,579 16,651 EBITDA (Core) 6,943 6,148 8,795 10,568 Growth, % (15.6) (11.5) 43.1 20.2 Margin, % 12.0 9.9 12.4 13.0 Depreciation 1,431 1,686 1,850 2,147 EBIT 5,512 4,462 6,945 8,420 Growth, % (22.9) (19.1) 55.7 21.2 Margin, % 9.6 7.2 9.8 10.4 Interest paid 817 974 1,116 1,368 Other Non Operating Income 186 295 384 481 Non recurring Items 0 0 0 0 Pre tax profit 4,881 3,783 6,213 7,532 Tax provided 1,064 1,340 1,926 2,335 Profit after tax 3,817 2,442 4,287 5,197 Others (Minorities, Associates) 303 230 303 303 Net Profit 4,120 2,673 4,590 5,500 Growth, % (10.0) (35.1) 71.7 19.8 Net Profit (adjusted) 4,120 2,673 4,590 5,500 Unadj. shares (m) 41 41 41 41 Wtd avg shares (m) 41 41 41 41 Balance Sheet Cash & bank 359 228 1,183 2,106 Debtors 6,138 7,599 8,673 9,905 Inventory 9,435 4,297 5,073 5,732 Loans & advances 1,845 1,845 1,845 1,845 Total current assets 17,777 13,968 16,774 19,588 Investments 2,375 2,375 2,375 2,375 Gross fixed assets 35,368 40,368 55,368 68,368 Less: Depreciation 10,843 12,529 14,379 16,526 Add: Capital WIP 3,263 3,263 3,263 3,263 Net fixed assets 27,788 31,102 44,252 55,104 Non current assets 1,518 1,518 1,518 1,518 Total assets 47,494 46,999 62,955 76,622 Current liabilities 13,272 12,986 14,306 15,427 Total current liabilities 13,272 12,986 14,306 15,427 Non current liabilities 9,781 7,781 18,781 26,781 Total liabilities 23,053 20,767 33,087 42,208 Paid up capital 405 405 405 405 Reserves & surplus 23,745 25,536 29,172 33,718 Shareholders equity 24,441 26,232 29,868 34,414 Total equity & liabilities 47,494 46,999 62,955 76,622 Cash Flow Pre tax profit 4,881 3,783 6,213 7,532 Depreciation 1,431 1,686 1,850 2,147 Chg in working capital 1,669 3,392 531 771 Total tax paid 667 1,340 1,926 2,335 Other operating activities 766 644 0 0 Cash flow from operating activities 4,742 8,164 5,606 6,574 Other investing activities 0 0 0 0 Cash flow from investing activities 6,000 5,000 15,000 13,000 Free cash flow 1,258 3,164 9,394 6,426 Debt raised/(repaid) 1,000 2,000 11,000 8,000 Other financing activities 1,428 1,625 1,768 2,019 Cash flow from financing activities 2,428 3,625 9,232 10,830 Net chg in cash 3,686 460 162 4,404 Valuation Ratios FY17 FY18 FY19e FY20e Per Share data EPS (INR) 101.2 65.7 112.8 135.1 Growth, % (10.0) (35.1) 71.7 19.8 Book NAV/share (INR) 593.4 637.4 726.7 838.4 CEPS (INR) 136.4 107.1 158.2 187.9 CFPS (INR) 91.3 177.5 128.3 149.7 Return ratios Return on assets (%) 10.6 7.2 9.8 9.4 Return on equity (%) 17.1 10.3 15.5 16.1 Return on capital employed (%) 15.0 10.0 13.1 11.9 Turnover ratios Asset turnover (x) 2.0 2.0 1.9 1.6 Sales/Total assets (x) 1.3 1.3 1.3 1.2 Sales/Net FA (x) 2.2 2.1 1.9 1.6 Working capital/sales (x) 0.1 0.0 0.0 0.0 Receivable days 38.9 44.5 44.5 44.5 Inventory days 59.7 25.2 26.0 25.8 Payable days 54.6 47.5 50.5 50.3 Working capital days 26.2 4.4 6.6 9.2 Liquidity ratios Current ratio (x) 1.3 1.1 1.2 1.3 Quick ratio (x) 0.6 0.7 0.8 0.9 Interest cover (x) 6.7 4.6 6.2 6.2 Total debt/equity (%) 37.7 27.4 61.2 76.5 Net debt/equity (%) 36.2 26.5 57.2 70.3 Valuation PER (x) 14.0 21.6 12.6 10.5 PEG (x) y o y growth (1.4) (0.6) 0.2 0.5 Price/Book (x) 2.4 2.2 2.0 1.7 EV/Net sales (x) 1.2 1.0 1.0 1.0 EV/EBITDA (x) 9.6 10.5 8.5 7.7 EV/EBIT (x) 12.1 14.5 10.7 9.7 Source: Company, PhillipCapital India Research Estimates Page 2 PHILLIPCAPITAL INDIA RESEARCH

Stock Price, Price Target and Rating History 2500 2000 1500 B (TP 1800) B (TP 2000) B (TP 2100) B (TP 2300) B (TP 2200) B (TP 1700) B (TP 2000) B (TP 1800) 1000 B (TP 1375) B (TP 1550) 500 0 J 16 F 16 M 16 M 16 J 16 A 16 S 16 N 16 D 16 F 17 M 17 M 17 J 17 J 17 S 17 O 17 D 17 J 18 M 18 A 18 J 18 J 18 Rating Methodology We rate stock on absolute return basis. Our target price for the stocks has an investment horizon of one year. Rating Criteria Definition BUY >= +15% Target price is equal to or more than 15% of current market price NEUTRAL 15% > to < +15% Target price is less than +15% but more than 15% SELL <= 15% Target price is less than or equal to 15%. Page 3 PHILLIPCAPITAL INDIA RESEARCH

Disclosures and Disclaimers PhillipCapital (India) Pvt. Ltd. has three independent equity research groups: Institutional Equities, Institutional Equity Derivatives, and Private Client Group. This report has been prepared by Institutional Equities Group. The views and opinions expressed in this document may, may not match, or may be contrary at times with the views, estimates, rating, and target price of the other equity research groups of PhillipCapital (India) Pvt. Ltd. This report is issued by PhillipCapital (India) Pvt. Ltd., which is regulated by the SEBI. PhillipCapital (India) Pvt. Ltd. is a subsidiary of Phillip (Mauritius) Pvt. Ltd. References to "PCIPL" in this report shall mean PhillipCapital (India) Pvt. Ltd unless otherwise stated. This report is prepared and distributed by PCIPL for information purposes only, and neither the information contained herein, nor any opinion expressed should be construed or deemed to be construed as solicitation or as offering advice for the purposes of the purchase or sale of any security, investment, or derivatives. The information and opinions contained in the report were considered by PCIPL to be valid when published. The report also contains information provided to PCIPL by third parties. The source of such information will usually be disclosed in the report. Whilst PCIPL has taken all reasonable steps to ensure that this information is correct, PCIPL does not offer any warranty as to the accuracy or completeness of such information. Any person placing reliance on the report to undertake trading does so entirely at his or her own risk and PCIPL does not accept any liability as a result. Securities and Derivatives markets may be subject to rapid and unexpected price movements and past performance is not necessarily an indication of future performance. This report does not regard the specific investment objectives, financial situation, and the particular needs of any specific person who may receive this report. Investors must undertake independent analysis with their own legal, tax, and financial advisors and reach their own conclusions regarding the appropriateness of investing in any securities or investment strategies discussed or recommended in this report and should understand that statements regarding future prospects may not be realised. Under no circumstances can it be used or considered as an offer to sell or as a solicitation of any offer to buy or sell the securities mentioned within it. The information contained in the research reports may have been taken from trade and statistical services and other sources, which PCIL believe is reliable. PhillipCapital (India) Pvt. Ltd. or any of its group/associate/affiliate companies do not guarantee that such information is accurate or complete and it should not be relied upon as such. Any opinions expressed reflect judgments at this date and are subject to change without notice. Important: These disclosures and disclaimers must be read in conjunction with the research report of which it forms part. Receipt and use of the research report is subject to all aspects of these disclosures and disclaimers. Additional information about the issuers and securities discussed in this research report is available on request. Certifications: The research analyst(s) who prepared this research report hereby certifies that the views expressed in this research report accurately reflect the research analyst s personal views about all of the subject issuers and/or securities, that the analyst(s) have no known conflict of interest and no part of the research analyst s compensation was, is, or will be, directly or indirectly, related to the specific views or recommendations contained in this research report. Additional Disclosures of Interest: Unless specifically mentioned in Point No. 9 below: 1. The Research Analyst(s), PCIL, or its associates or relatives of the Research Analyst does not have any financial interest in the company(ies) covered in this report. 2. The Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively do not hold more than 1% of the securities of the company (ies)covered in this report as of the end of the month immediately preceding the distribution of the research report. 3. The Research Analyst, his/her associate, his/her relative, and PCIL, do not have any other material conflict of interest at the time of publication of this research report. 4. The Research Analyst, PCIL, and its associates have not received compensation for investment banking or merchant banking or brokerage services or for any other products or services from the company(ies) covered in this report, in the past twelve months. 5. The Research Analyst, PCIL or its associates have not managed or co managed in the previous twelve months, a private or public offering of securities for the company (ies) covered in this report. 6. PCIL or its associates have not received compensation or other benefits from the company(ies) covered in this report or from any third party, in connection with the research report. 7. The Research Analyst has not served as an Officer, Director, or employee of the company (ies) covered in the Research report. 8. The Research Analyst and PCIL has not been engaged in market making activity for the company(ies) covered in the Research report. 9. Details of PCIL, Research Analyst and its associates pertaining to the companies covered in the Research report: Sr. no. Particulars Yes/No 1 Whether compensation has been received from the company(ies) covered in the Research report in the past 12 months for No investment banking transaction by PCIL 2 Whether Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively hold more than 1% of No the company(ies) covered in the Research report 3 Whether compensation has been received by PCIL or its associates from the company(ies) covered in the Research report No 4 PCIL or its affiliates have managed or co managed in the previous twelve months a private or public offering of securities for the No company(ies) covered in the Research report 5 Research Analyst, his associate, PCIL or its associates have received compensation for investment banking or merchant banking or brokerage services or for any other products or services from the company(ies) covered in the Research report, in the last twelve months No Independence: PhillipCapital (India) Pvt. Ltd. has not had an investment banking relationship with, and has not received any compensation for investment banking services from, the subject issuers in the past twelve (12) months, and PhillipCapital (India) Pvt. Ltd does not anticipate receiving or intend to seek compensation for investment banking services from the subject issuers in the next three (3) months. PhillipCapital (India) Pvt. Ltd is not a market maker in the securities mentioned in this research report, although it, or its affiliates/employees, may have positions in, purchase or sell, or be materially interested in any of the securities covered in the report. Suitability and Risks: This research report is for informational purposes only and is not tailored to the specific investment objectives, financial situation or particular requirements of any individual recipient hereof. Certain securities may give rise to substantial risks and may not be suitable for certain investors. Each investor must make its own determination as to the appropriateness of any securities referred to in this research report based upon the legal, tax and accounting considerations applicable to such investor and its own investment objectives or strategy, its financial situation and its investing experience. The value of any security may be positively or adversely affected by changes in foreign exchange or interest rates, as well as by other financial, economic, or political factors. Past performance is not necessarily indicative of future performance or results. Page 4 PHILLIPCAPITAL INDIA RESEARCH

Sources, Completeness and Accuracy: The material herein is based upon information obtained from sources that PCIPL and the research analyst believe to be reliable, but neither PCIPL nor the research analyst represents or guarantees that the information contained herein is accurate or complete and it should not be relied upon as such. Opinions expressed herein are current opinions as of the date appearing on this material, and are subject to change without notice. Furthermore, PCIPL is under no obligation to update or keep the information current. Without limiting any of the foregoing, in no event shall PCIL, any of its affiliates/employees or any third party involved in, or related to computing or compiling the information have any liability for any damages of any kind including but not limited to any direct or consequential loss or damage, however arising, from the use of this document. Copyright: The copyright in this research report belongs exclusively to PCIPL. All rights are reserved. Any unauthorised use or disclosure is prohibited. No reprinting or reproduction, in whole or in part, is permitted without the PCIPL s prior consent, except that a recipient may reprint it for internal circulation only and only if it is reprinted in its entirety. Caution: Risk of loss in trading/investment can be substantial and even more than the amount / margin given by you. Investment in securities market are subject to market risks, you are requested to read all the related documents carefully before investing. You should carefully consider whether trading/investment is appropriate for you in light of your experience, objectives, financial resources and other relevant circumstances. PhillipCapital and any of its employees, directors, associates, group entities, or affiliates shall not be liable for losses, if any, incurred by you. You are further cautioned that trading/investments in financial markets are subject to market risks and are advised to seek independent third party trading/investment advice outside PhillipCapital/group/associates/affiliates/directors/employees before and during your trading/investment. There is no guarantee/assurance as to returns or profits or capital protection or appreciation. PhillipCapital and any of its employees, directors, associates, and/or employees, directors, associates of PhillipCapital s group entities or affiliates is not inducing you for trading/investing in the financial market(s). Trading/Investment decision is your sole responsibility. You must also read the Risk Disclosure Document and Do s and Don ts before investing. Kindly note that past performance is not necessarily a guide to future performance. For Detailed Disclaimer: Please visit our website www.phillipcapital.in For U.S. persons only: This research report is a product of PhillipCapital (India) Pvt Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances, and trading securities held by a research analyst account. This report is intended for distribution by PhillipCapital (India) Pvt Ltd. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by the U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated, and/or transmitted onward to any U.S. person, which is not a Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a 6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, PhillipCapital (India) Pvt Ltd. has entered into an agreement with a U.S. registered broker dealer, Decker & Co, LLC. Transactions in securities discussed in this research report should be effected through Decker & Co, LLC or another U.S. registered broker dealer. If Distribution is to Australian Investors This report is produced by PhillipCapital (India) Pvt Ltd and is being distributed in Australia by Phillip Capital Limited (Australian Financial Services Licence No. 246827). This report contains general securities advice and does not take into account your personal objectives, situation and needs. Please read the Disclosures and Disclaimers set out above. By receiving or reading this report, you agree to be bound by the terms and limitations set out above. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately. PhillipCapital (India) Pvt. Ltd. Registered office: No. 1, 18th Floor, Urmi Estate, 95 Ganpatrao Kadam Marg, Lower Parel West, Mumbai 400013 Page 5 PHILLIPCAPITAL INDIA RESEARCH